Center for Healthcare Transformation, Queensland University of Technology, Brisbane, QLD, Australia.
Department of Nursing and Midwifery, Faculty of Allied Health Sciences, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka.
BMC Endocr Disord. 2024 Nov 29;24(1):258. doi: 10.1186/s12902-024-01774-3.
Recent evidence suggests that diabetes-related lower-extremity complications (DRLECs) may be associated with cognitive changes in people with diabetes. However, existing literature has produced inconsistent findings, and no systematic reviews have been conducted to investigate whether DRLECs impact the cognition of people with diabetes. This systematic review evaluated existing studies that investigated cognition in people with diabetes with DRLECs and without DRLECs.
Seven databases; MEDLINE, PubMed, CINAHL, EMBASE, Cochrane, PsycINFO and Web of Science were searched from inception until 22/8/2022 for studies that compared cognition in people with diabetes with and without DRLECs. Results were independently screened for eligibility and assessed for methodological quality by two authors, with key data extracted. Studies were eligible for meta-analysis if the studies reported similar cases, controls, and outcome measures.
Thirteen studies were included in the review, with eleven of medium methodological quality, one of high quality, and one of low quality. Four studies found significant differences in cognition between those with and without DRLECs, four found significant associations between diabetes-related lower-extremity complications and cognition, and five found no differences or associations. One small meta-analysis of eligible studies found that there was no statistically significant difference in cognition in people without, compared to with, peripheral neuropathy (Mean difference = -0.49; 95%CI: -1.59-0.61; N = 3; n = 215). Leave-one-out sensitivity analyses further confirmed that there was no significant difference in cognition among people with and without peripheral neuropathy (p > 0.05).
DRLECs may be related to cognition in people with diabetes, however, existing evidence is unclear due to variability in used methodologies that may challenge concluding the findings. Future high-quality studies investigating cognition among people with and without DRLECs are needed.
最近的证据表明,糖尿病相关的下肢并发症(DRLECs)可能与糖尿病患者的认知变化有关。然而,现有文献的研究结果并不一致,也没有系统评价来调查 DRLECs 是否会影响糖尿病患者的认知功能。本系统评价评估了现有的研究,这些研究调查了有和没有 DRLECs 的糖尿病患者的认知功能。
从建库开始至 2022 年 8 月 22 日,我们在 7 个数据库(MEDLINE、PubMed、CINAHL、EMBASE、Cochrane、PsycINFO 和 Web of Science)中搜索了比较有和没有 DRLECs 的糖尿病患者认知功能的研究。两位作者独立筛选研究的合格性并评估方法学质量,提取关键数据。如果研究报告了相似的病例、对照和结局测量,研究则有资格进行荟萃分析。
本综述共纳入了 13 项研究,其中 11 项研究的方法学质量为中等,1 项研究为高质量,1 项研究为低质量。四项研究发现有和没有 DRLECs 的患者之间的认知功能存在显著差异,四项研究发现糖尿病相关的下肢并发症与认知功能之间存在显著关联,五项研究未发现差异或关联。对符合条件的研究进行的一项小型荟萃分析发现,无周围神经病变的患者与有周围神经病变的患者相比,认知功能没有统计学上的显著差异(平均差异=-0.49;95%CI:-1.59-0.61;N=3;n=215)。逐一剔除敏感分析进一步证实,有周围神经病变和无周围神经病变的患者之间的认知功能没有显著差异(p>0.05)。
DRLECs 可能与糖尿病患者的认知功能有关,但由于使用的方法学存在差异,导致现有证据不明确,难以得出结论。需要进行未来高质量的研究,调查有和没有 DRLECs 的糖尿病患者的认知功能。